These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 813557)

  • 1. Biochemistry of malignant melanoma.
    Schwartz MK
    Ann Clin Lab Sci; 1976; 6(1):56-64. PubMed ID: 813557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
    Duchon J; Matous B; Pavel S
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):139-44. PubMed ID: 97931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine release and tyrosinase activity in amelanotic and melanotic malignant melanoma.
    Satoh GJ; Mishima Y
    J Invest Dermatol; 1969 Jan; 52(1):107-10. PubMed ID: 4973526
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemistry of melanin synthesis: in vivo effects of MSH on tyrosinase and melanogenesis of pigmentary system.
    Lee TH; Lee MS
    Yale J Biol Med; 1973 Dec; 46(5):493-9. PubMed ID: 4205116
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanogenesis in human melanomas.
    Chen YM; Chavin W
    Cancer Res; 1975 Mar; 35(3):606-12. PubMed ID: 803870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical markers of malignant melanoma.
    Matous B; Cigánek EF; Budĕsínská A; Duchon J
    Neoplasma; 1987; 34(1):77-84. PubMed ID: 3104808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenothiazines on melanoma tyrosinase activity.
    Van Woert MH
    J Pharmacol Exp Ther; 1970 Jun; 173(2):256-64. PubMed ID: 4988494
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the clinical laboratory in the diagnosis and management of malignant melanoma.
    Scott RE; Wilson DM
    Mayo Clin Proc; 1989 Jul; 64(7):837-45. PubMed ID: 2671522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxidase, "protyrosinase," and the multiple forms of tyrosinase in mice.
    Holstein TJ; Stowell CP; Quevedo WC; Zarcaro RM; Bienieki TC
    Yale J Biol Med; 1973 Dec; 46(5):560-71. PubMed ID: 4205122
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of tyrosinase in melanin formation in murine melanoma.
    Hearing VJ; Ekel TM
    J Invest Dermatol; 1975 Feb; 64(2):80-5. PubMed ID: 804529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of urinary melanogens in patients with melanosarcoma].
    Humbel R
    Pharm Acta Helv; 1972 Jan; 47(1):29-40. PubMed ID: 5013185
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-premelanosomal and premelanosomal tyrosinase activity in Greene's amelanotic and melanotic malignant melanoma.
    Mishima Y; Adams JF
    Cancer; 1969 Apr; 23(4):952-7. PubMed ID: 4975667
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.
    Lee TH; Lee MS; Lu MY
    Endocrinology; 1972 Nov; 91(5):1180-8. PubMed ID: 4627367
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of melanin as tyrosine equivalents and as weight of purified melanin.
    Oikawa A; Nakayasu M
    Yale J Biol Med; 1973 Dec; 46(5):500-7. PubMed ID: 4205117
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indole melanogens--useful tumor markers in malignant melanoma?].
    Ghussen F; Nagel K; Groth W; Horbach G
    Z Hautkr; 1985 Oct; 60(20):1613-9. PubMed ID: 4060826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies.
    Sohn N; Gang H; Gumport SL; Goldstein M; Deppisch LM
    Cancer; 1969 Nov; 24(5):897-903. PubMed ID: 4982120
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of tyrosinase-catalyzed melanin formation by catechol phenyl sulfones.
    Siuda JF; Habal A
    J Med Chem; 1974 Nov; 17(11):1173-7. PubMed ID: 4213190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.